These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30736969)

  • 1. Three years' experience of dialysis event surveillance.
    Abdelfattah RR; Al-Jumaah S; Al-Korbi L; Al-Qahtani T
    Am J Infect Control; 2019 Jul; 47(7):793-797. PubMed ID: 30736969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014.
    Nguyen DB; Shugart A; Lines C; Shah AB; Edwards J; Pollock D; Sievert D; Patel PR
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1139-1146. PubMed ID: 28663227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
    Poinen K; Quinn RR; Clarke A; Ravani P; Hiremath S; Miller LM; Blake PG; Oliver MJ
    Am J Kidney Dis; 2019 Apr; 73(4):467-475. PubMed ID: 30642607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for infections and other adverse events in dialysis patients in southern Gran Canaria.
    Quori A; Baamonde-Laborda E; García-Cantón C; Lago-Alonso MM; Toledo-González A; Monzón-Jiménez E; Jiménez-Díaz D; Checa-de-Andrés M; Molina-Cabrillana J
    Nefrologia; 2011; 31(4):457-63. PubMed ID: 21623394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients; a cohort study.
    Mohamed H; Ali A; Browne LD; O'Connell NH; Casserly L; Stack AG; Hussein WF
    BMC Nephrol; 2019 Feb; 20(1):68. PubMed ID: 30808313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Analysis of Dialysis Events over a 3-Year Period in an Outpatient Dialysis Unit in the State of Kuwait.
    Ramadan MA; Hebbar G
    Med Princ Pract; 2018; 27(4):337-342. PubMed ID: 29301135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of a Patient with Catheter-Related Bloodstream Infection.
    Lok CE
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1873-1877. PubMed ID: 28679561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Temporary and permanent central venous catheters for hemodialysis].
    Premužić V; Tomašević B; Eržen G; Makar K; Brunetta-Gavranić B; Francetić I; Bašić-Jukić N; Kes P; Jelaković B
    Acta Med Croatica; 2014 Apr; 68(2):167-74. PubMed ID: 26012155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis catheter-related infection: prophylaxis, diagnosis and treatment.
    Böhlke M; Uliano G; Barcellos FC
    J Vasc Access; 2015; 16(5):347-55. PubMed ID: 25907773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Concepts in Hemodialysis Vascular Access Infections.
    Kumbar L; Yee J
    Adv Chronic Kidney Dis; 2019 Jan; 26(1):16-22. PubMed ID: 30876612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.
    Lee T; Thamer M; Zhang Q; Zhang Y; Allon M
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1823-1830. PubMed ID: 28798220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.
    Arhuidese IJ; Orandi BJ; Nejim B; Malas M
    J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes.
    Aminzadeh Z; Simpson P; Athan E
    Infect Dis Health; 2019 Nov; 24(4):222-228. PubMed ID: 31401054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organism-specific bacteremia by hemodialysis access.
    Zhang J; Burr RA; Sheth HS; Piraino B
    Clin Nephrol; 2016 Sep; 86(9):141-6. PubMed ID: 27443564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of infections and antimicrobial use among hemodialysis outpatients: A prospective multicenter study.
    Wu YL; Zhang JJ; Li RJ; Cai CY; Zhang YH; Xu TM; Jiang Y; Xu L; Yang LQ; Yang XY
    Semin Dial; 2020 Mar; 33(2):156-162. PubMed ID: 32160343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of vascular access infections at seven outpatient hemodialysis centers.
    Tokars JI; Light P; Anderson J; Miller ER; Parrish J; Armistead N; Jarvis WR; Gehr T
    Am J Kidney Dis; 2001 Jun; 37(6):1232-40. PubMed ID: 11382693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center: a case-control study.
    Fram D; Okuno MF; Taminato M; Ponzio V; Manfredi SR; Grothe C; Belasco A; Sesso R; Barbosa D
    BMC Infect Dis; 2015 Mar; 15():158. PubMed ID: 25879516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
    Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
    Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surveillance for bacteremia related to vascular access in hemodialysis].
    Ferrero S; Saltarelli M; Quori A; Campobasso M; Argentero PA
    G Ital Nefrol; 2008; 25(3):347-53. PubMed ID: 18473306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.
    Brunelli SM; Van Wyck DB; Njord L; Ziebol RJ; Lynch LE; Killion DP
    J Am Soc Nephrol; 2018 Apr; 29(4):1336-1343. PubMed ID: 29472415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.